Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.39

ANIP FY 2006 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

FY 2006 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$14M

Gross Profit

$14M100.0% margin

Operating Income

$3M23.8% margin

Net Income

$3M19.3% margin

EPS (Diluted)

$4.68

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$22M

Total Liabilities

$4M

Stockholders' Equity

$18M

Cash & Equivalents

$8M

← FY 2007 All Quarters